well gkm, pretty much what i expected from you...
it's not me harping on about delay, it's about a ceo, the face of a company, the 'professional' who approves the wording of market announcements - who repeatedly now has shown himself prepared to overstate, overhype, over-estimate too many critical milestones - he's a hype salesman who uses the wrong words, verging on being false and misleading... that his use of incorrect terminology results in delays is a direct symptom of his mode of management, or mis-management from where i sit...
but he has you in his corner, so all is good in the world of biotechs, because you know biotechs, and the way they work - truly a sensational expertise you have there gkm
as for your investment advice, and particular in respect of biotechs, and especially TIS.. well i wouldn't be the first here to tell you to save it for yourself, mate
anyhoos, have a superb weekend reading up on, and reading between the lines of the aussie biotech community - your crystal ball really is something else...
good luck
- Forums
- ASX - By Stock
- TIS
- mercer should go...
mercer should go..., page-4
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)